Anti-Osteoporotic Effects of Commiphora Myrrha and Its Poly-Saccharide via Osteoclastogenesis Inhibition

In traditional oriental medicines, <i>Commiphora myrrha</i> and its resinous exudate (i.e., myrrh) are used as herbal remedies to treat various inflammatory and metabolic disorders. Until now, <i>C. myrrha</i>-derived herbal products are considered useful source for bioactive...

Full description

Bibliographic Details
Main Authors: Youn-Hwan Hwang, Ami Lee, Taesoo Kim, Seon-A Jang, Hyunil Ha
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Plants
Subjects:
Online Access:https://www.mdpi.com/2223-7747/10/5/945
_version_ 1797534777229705216
author Youn-Hwan Hwang
Ami Lee
Taesoo Kim
Seon-A Jang
Hyunil Ha
author_facet Youn-Hwan Hwang
Ami Lee
Taesoo Kim
Seon-A Jang
Hyunil Ha
author_sort Youn-Hwan Hwang
collection DOAJ
description In traditional oriental medicines, <i>Commiphora myrrha</i> and its resinous exudate (i.e., myrrh) are used as herbal remedies to treat various inflammatory and metabolic disorders. Until now, <i>C. myrrha</i>-derived herbal products are considered useful source for bioactive compounds to manage numerous human diseases. This study investigated the effects of water extract of <i>C. myrrha</i> resin (WCM) and its polysaccharide (WCM-PE) on modulatory effects of osteoclast differentiation and/or ovariectomized-induced bone loss. Oral administration of WCM (200 and 500 mg/kg/day for four weeks) notably decreased trabecular bone loss and lipid accumulation in the bone marrow cavity. WCM and WCM-PE dose-dependently inhibited receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis and suppressed RANKL-mediated overexpression of c-Fos and nuclear factor of activated T cells, cytoplasmic 1, thereby downregulating osteoclast-specific gene (Atp6v0d2, DC-STAMP and cathepsin K) expression. Thus, our results suggest that WCM and WCM-PE are promising nutraceutical candidates for the management of osteoporosis in postmenopausal women.
first_indexed 2024-03-10T11:35:17Z
format Article
id doaj.art-13ee05dbae2b4c7fb20d2a3427d3b7e2
institution Directory Open Access Journal
issn 2223-7747
language English
last_indexed 2024-03-10T11:35:17Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Plants
spelling doaj.art-13ee05dbae2b4c7fb20d2a3427d3b7e22023-11-21T18:55:06ZengMDPI AGPlants2223-77472021-05-0110594510.3390/plants10050945Anti-Osteoporotic Effects of Commiphora Myrrha and Its Poly-Saccharide via Osteoclastogenesis InhibitionYoun-Hwan Hwang0Ami Lee1Taesoo Kim2Seon-A Jang3Hyunil Ha4Herbal Medicine Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, KoreaHerbal Medicine Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, KoreaHerbal Medicine Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, KoreaHerbal Medicine Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, KoreaHerbal Medicine Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, KoreaIn traditional oriental medicines, <i>Commiphora myrrha</i> and its resinous exudate (i.e., myrrh) are used as herbal remedies to treat various inflammatory and metabolic disorders. Until now, <i>C. myrrha</i>-derived herbal products are considered useful source for bioactive compounds to manage numerous human diseases. This study investigated the effects of water extract of <i>C. myrrha</i> resin (WCM) and its polysaccharide (WCM-PE) on modulatory effects of osteoclast differentiation and/or ovariectomized-induced bone loss. Oral administration of WCM (200 and 500 mg/kg/day for four weeks) notably decreased trabecular bone loss and lipid accumulation in the bone marrow cavity. WCM and WCM-PE dose-dependently inhibited receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis and suppressed RANKL-mediated overexpression of c-Fos and nuclear factor of activated T cells, cytoplasmic 1, thereby downregulating osteoclast-specific gene (Atp6v0d2, DC-STAMP and cathepsin K) expression. Thus, our results suggest that WCM and WCM-PE are promising nutraceutical candidates for the management of osteoporosis in postmenopausal women.https://www.mdpi.com/2223-7747/10/5/945myrrhpolysaccharideosteoporosisosteoclastogenesismice
spellingShingle Youn-Hwan Hwang
Ami Lee
Taesoo Kim
Seon-A Jang
Hyunil Ha
Anti-Osteoporotic Effects of Commiphora Myrrha and Its Poly-Saccharide via Osteoclastogenesis Inhibition
Plants
myrrh
polysaccharide
osteoporosis
osteoclastogenesis
mice
title Anti-Osteoporotic Effects of Commiphora Myrrha and Its Poly-Saccharide via Osteoclastogenesis Inhibition
title_full Anti-Osteoporotic Effects of Commiphora Myrrha and Its Poly-Saccharide via Osteoclastogenesis Inhibition
title_fullStr Anti-Osteoporotic Effects of Commiphora Myrrha and Its Poly-Saccharide via Osteoclastogenesis Inhibition
title_full_unstemmed Anti-Osteoporotic Effects of Commiphora Myrrha and Its Poly-Saccharide via Osteoclastogenesis Inhibition
title_short Anti-Osteoporotic Effects of Commiphora Myrrha and Its Poly-Saccharide via Osteoclastogenesis Inhibition
title_sort anti osteoporotic effects of commiphora myrrha and its poly saccharide via osteoclastogenesis inhibition
topic myrrh
polysaccharide
osteoporosis
osteoclastogenesis
mice
url https://www.mdpi.com/2223-7747/10/5/945
work_keys_str_mv AT younhwanhwang antiosteoporoticeffectsofcommiphoramyrrhaanditspolysaccharideviaosteoclastogenesisinhibition
AT amilee antiosteoporoticeffectsofcommiphoramyrrhaanditspolysaccharideviaosteoclastogenesisinhibition
AT taesookim antiosteoporoticeffectsofcommiphoramyrrhaanditspolysaccharideviaosteoclastogenesisinhibition
AT seonajang antiosteoporoticeffectsofcommiphoramyrrhaanditspolysaccharideviaosteoclastogenesisinhibition
AT hyunilha antiosteoporoticeffectsofcommiphoramyrrhaanditspolysaccharideviaosteoclastogenesisinhibition